Bridgewell provides tailored M&A advisory services for healthcare owner-operators and physician practices who have created significant value and are seeking the next step in their business’s evolution.
Every engagement begins with active listening and ends with decisive execution. We don’t apply a generic playbook. We build a framework around your business, your goals, and your timeline.
Before any process begins, we invest time in understanding your personal, professional, and financial objectives and those of any other key stakeholders involved in the business.
This stage sets the foundation. It’s about gaining clarity regarding where you are and where you want to go, before committing to a specific path forward.
Defining personal, financial, and professional objectives for all key stakeholders before any decisions are made.
Understanding your runway, urgency, and openness to different outcomes, critical inputs that shape everything that follows.
Identifying internal and external stakeholders whose alignment is essential to a successful outcome.
We analyze the business to identify and enhance value drivers, optimize positioning, mitigate concerns, and clearly define growth opportunities, preparing the business for future success regardless of the path chosen.
This is where the most value is created.
Identifying the key factors that drive enterprise value and building a plan to enhance them.
Surfacing and addressing concerns that could reduce value or complicate a process before they become issues.
Crafting a compelling, credible story that positions the business clearly for buyers, investors, or partners.
We help determine the best course of action that aligns with your business strategy and goals. The range of options is broader than most owners realize, and an honest evaluation of all of them is essential to finding the right path.
An evaluation of the full range of options is important to ensure the ideal path forward, not just the most common one.
Pursuing a full sale to a strategic acquirer or platform positioned to maximize value and deliver a clean transition.
Structuring a partial liquidity event that lets owners take chips off the table while retaining meaningful upside.
Helping you grow by identifying and acquiring complementary businesses that add scale, capability, or reach.
Continuing to build the business independently, with a plan centered on organic growth and long-term value creation.
We design a customized process and manage every detail, from initial outreach through final negotiations, ensuring no opportunity is missed and no detail is left to chance.
Upfront preparation translates into tangible results.
We design each process to meet the unique needs of each business.
Driving the process forward day to day, keeping momentum, timelines, and stakeholders aligned through close.
Negotiating terms that protect your interests and managing diligence through to a clean, efficient close.
Two decades of shaping outcomes for owners means we’ve seen what works and what doesn’t across deal structures and market cycles. That experience shapes every engagement.
You work directly with experienced advisors, not junior analysts, at every stage of the engagement.
We advise from the owner’s seat, understanding that transactions are deeply personal, not just financial events.
Rigorous preparation and disciplined execution translate directly into better terms, better partners, and better outcomes.
Original research, market reviews, and deal commentary.




View our weekly Market Insights hub here for the latest headlines, deal activity, and investment themes.
DOJ declines to prosecute Campus Eye Management Holdings under its new Corporate Enforcement Policy, indicts founder.
BECKER'S ASCAstrana Health reports Q2 2026 revenue of $972.5M (+49% YoY), raises full-year Adjusted EBITDA guidance.
PR NEWSWIREHinge Health signs definitive agreement to acquire Cylinder Health for $105M, expanding into virtual-first GI care.
FIERCE HEALTHCAREHealthBar selects Elation Health as its EHR platform to power employer-based primary care at scale.
BUSINESSWIREClearview Capital exits Advantage Behavioral Health in a $610M muni-bond-financed sale to nonprofit QCF/I, Inc.
LAWRENCE, EVANS & CO.Serelora acquires ACTIN Care Groups' clinical risk-stratification software, extending its agentic EHR into population health.
LAWRENCE, EVANS & CO.
*
*
*
*
a portfolio company of
*
a portfolio company of
*
a portfolio company of
*
*
* Denotes transaction completed by a Bridgewell Managing Partner at a prior firm.
Whether you're actively exploring a transaction or just beginning to think through your options, we start every relationship with a direct, confidential conversation.
Monthly headlines, deal activity, and investment themes across the sector.
Under the Department's new Corporate Enforcement Policy, DOJ declined to prosecute the PE-backed optometry MSO for healthcare fraud and kickbacks after it self-disclosed, cooperated, and paid $1M in restitution, marking the first healthcare declination under the policy. Founder E. Bruce DiDonato was separately indicted on a seven-count fraud and kickback scheme tied to the 2021 PE recapitalization.
Becker's ASC / DOJ, Aug 7Revenue of $972.5M (+49% YoY), net income of $19.7M (+109% YoY), and Adjusted EBITDA of $68.9M (+43% YoY) for the quarter; management raised full-year 2026 Adjusted EBITDA guidance to $255–280M, citing accelerating provider and payer demand for its value-based care platform.
PR Newswire, Aug 6The combination pairs Included Health's clinician-in-the-loop virtual care and navigation platform with Firefly's clinically integrated health plan design, serving 20,000+ members through 2,300+ providers; Firefly reported 15%+ total cost of care savings and 90% member satisfaction in 2025. Expected to close Q3 2026.
BusinessWire, Jul 28Connecticut-based PE firm Clearview agreed to sell the New Jersey mental health and sober-living operator to nonprofit acquirer QCF/I, Inc., funded via a planned $610M unrated municipal bond issuance; Clearview and management expect ~$415M at closing, with up to $100M more tied to performance. ABH is projected to generate ~$170M revenue and ~$78M EBITDA this year.
Lawrence, Evans & Co. · Weekly Healthcare Digest, Aug 3The buyer adds the Washington-state bariatric and weight-loss surgery practice, along with Sound Weight & Wellness, extending its strategy of building an outpatient surgical facility portfolio.
McGuireWoods, Jul 29The East Texas DPC practice, founded in 2014, joins Timshel's national holding company and plans to open new clinics across Texas; founder Jeremy Smith, MD becomes MyMD Select's chief medical officer under the deal.
BusinessWire, Jul 30PE is pulling back from broad physician rollups, redirecting capital toward differentiated platforms in behavioral health, fertility, dermatology and dental DSOs, alongside MSK/orthopedics and home health.
Both specialties are seeing modest multiple compression after several consolidation waves, with sponsors emphasizing operational integration and margin optimization over pure roll-up growth.
Nonprofit and mission-aligned buyers are emerging as credible exit paths, as seen in Clearview Capital's $610M muni-bond-financed sale of Advantage Behavioral Health to nonprofit acquirer QCF/I.
79+ state bills addressing PE/investor-backed ownership introduced across 26 states in 2026, with holding periods lengthening beyond five years and dividend recapitalization structures under increasing physician and regulator scrutiny.
| Date | Target | Acquirer | Value | Type | Rationale |
|---|---|---|---|---|---|
| Jul 31 | Advantage Behavioral Health | QCF/I, Inc. | $610M | Nonprofit / Muni-Bond | Clearview Capital exits behavioral health platform via municipal-bond-financed nonprofit acquisition. |
| Jul 29 | Sound Surgeons | Transform Health Partners | N/D | PE Platform | Bariatric/weight-loss surgery practice joins outpatient surgical portfolio in Washington state. |
| Jul 28 | Firefly Health | Included Health | N/D | Strategic | Clinically integrated health plan alternative combines with AI-native virtual care/navigation platform; expected to close Q3 2026. |
| Company | Ticker | Price | Mkt Cap ($B) | TEV / Revenue | TEV / EBITDA |
|---|---|---|---|---|---|
| Privia Health | PRVA | $21.33 | $2.7 | 1.1x | 45.9x |
| Astrana Health | ASTH | $34.13 | $1.5 | 0.6x | 12.9x |
| Evolent Health | EVH | $3.82 | $0.4 | 0.6x | N/M |
| CVS Health | CVS | $95.49 | $122.1 | 0.4x | 14.4x |
| U.S. Physical Therapy | USPH | $77.71 | $1.2 | 1.9x | 14.8x |
| Surgery Partners | SGRY | $14.92 | $1.9 | 1.7x | 10.2x |
| RadNet | RDNT | $71.19 | $5.6 | 3.3x | 24.2x |
| Pediatrix Medical Group | MD | $25.99 | $2.1 | 1.2x | 9.6x |
| Average | — | — | — | 1.3x | 18.9x |
The publicly traded digital MSK platform expands into virtual-first gastrointestinal care, combining Cylinder's clinical expertise with Hinge's technology into a single app targeted for a 2027 launch; deal expected to close Q3 2026.
Fierce Healthcare, Aug 4Elation's clinical-first EHR platform will support HealthBar's onsite and virtual preventive-care offering, which serves dozens of employers and schools nationally, as the company continues its expansion.
BusinessWire, Aug 3The deal, which closed in Cleveland, unifies inpatient coordination, remote patient monitoring, chronic care management and cardiac AI into a single Epic-native workflow, part of a broader push among health tech providers toward integrated inpatient-to-post-acute platforms.
PR Newswire, Jul 23The acquired WellCheck technology, a 27-instrument preventive risk battery, becomes a native capability of Serelora's agentic EHR, extending it from individual-chart documentation into population-level risk analysis.
Lawrence, Evans & Co. · Weekly Healthcare Digest, Aug 3Agentic AI and virtual-care consolidation continue to reshape the sector, with platforms increasingly acquiring adjacent clinical and monitoring capabilities to build unified, hospital-to-home care operating systems, as seen in Nexus/Telemetrix and Hinge Health/Cylinder Health this week.
Agentic EHR platforms are moving beyond documentation into population-level risk analytics, as seen in Serelora's acquisition of ACTIN Care Groups' WellCheck risk-stratification technology.
Q1 2026 recorded 95 Health IT M&A/buyout transactions, including 18 high-quality buyouts, on pace to approximate 2025's near-record buyout levels. Market caution is concentrated at the upper end of the market; the lower end remains resilient.
Sponsor interest remains concentrated in governance, risk and compliance (GRC) tooling, with pharma services and pharma tech outsourcing expected to draw additional capital as pharma companies look to reduce cost and time-to-market.
ONC/HHS confirmed active enforcement of information-blocking rules for the first time since the 21st Century Cures Act, with product decertification now an explicit consequence; TEFCA has scaled to 600M+ documents exchanged across 75,000 connections.
| Date | Target | Acquirer | Value | Type | Rationale |
|---|---|---|---|---|---|
| Aug 4 | Cylinder Health | Hinge Health | $105M | Strategic | Digital MSK platform expands into virtual-first gastrointestinal care; expected to close Q3 2026. |
| Jul 23 | Telemetrix RPM | Nexus | N/D | Strategic | Remote patient monitoring and chronic care management platform joins Epic-native inpatient-to-home care system. |
| Jul 29 | ACTIN Care Groups (risk software) | Serelora | N/D | Tech Tuck-in | Agentic EHR platform adds population-level clinical risk-stratification capability. |
| Company | Ticker | Price | Mkt Cap ($B) | TEV / Revenue | TEV / EBITDA |
|---|---|---|---|---|---|
| Doximity | DOCS | $28.72 | $5.2 | 6.7x | 21.1x |
| Phreesia | PHR | $12.61 | $0.8 | 1.6x | 18.3x |
| Oracle | ORCL | $145.09 | $417.9 | 8.2x | 18.5x |
| Waystar Holding | WAY | $24.46 | $4.7 | 5.0x | 13.8x |
| Claritev (fka MultiPlan) | CTEV | $32.59 | $0.6 | 5.3x | 10.5x |
| HealthStream | HSTM | $28.12 | $0.8 | 2.4x | 10.9x |
| Health Catalyst | HCAT | $2.23 | $0.2 | 0.8x | N/M |
| Evolent Health | EVH | $3.95 | $0.4 | 0.6x | N/M |
| HealthEquity | HQY | $104.63 | $8.7 | 7.1x | 19.1x |
| Hinge Health | HNGE | $89.33 | $7.2 | 9.4x | N/M |
| Talkspace* | TALK | $5.22 | $0.9 | 3.2x | N/M |
| Average | — | — | — | 4.6x | 16.0x |
Check out our original research and market commentary below.










Our track record of successful outcomes is the result of our relentless pursuit of excellence for each of our clients.
*
*
*
*
a portfolio company of
*
a portfolio company of
*
*
a portfolio company of
*
*
*
a portfolio company of
*
*
*
a portfolio company of
*
a portfolio company of
*
*
a portfolio company of
*
a portfolio company of
*
Firm announcements, articles, and conference attendance.






How Bridgewell Advisory collects, uses, and protects your information.
Effective Date: September 8, 2026
Bridgewell Advisory (“Bridgewell,” “we,” “our,” or “us”) is a service of Bridgewell LLC. We value your privacy and are committed to protecting the personal information you share with us. This Privacy Policy outlines how we collect, use, disclose, and safeguard your information when you visit our website https://bridgewell-advisory.com, its subdomains, content, and services, or interact with us otherwise (the “Site”).
Personal information means any identifying information, usually your name in combination with another identifier, such as an email address, phone number, or company name. Personal information does not include anonymous or aggregated data that can no longer be used to identify a specific person. The specific definition of personal information varies from one jurisdiction to another.
Personal information is collected directly from you and automatically.
We may receive personal information about you from third-party sources such as marketing partners, social media platforms, or CRM tools if you have granted them permission to share data with us.
We use the collected data to:
We may disclose your data with others in compliance with this Privacy Policy, as indicated below:
We use cookies and similar technologies to enhance your experience. Cookies are small data files that help us keep track of your usage of the Site. Persistent cookies remember your preferences from one visit to the next, and session cookies support your current visit — both help us enhance the user experience and analyze how the Site is used.
We use the following categories of cookies on the Site:
You can control cookies through your browser settings, or opt out of certain third-party tracking via tools such as the Network Advertising Initiative.
The Site does not respond to browsers’ Do Not Track signals. When we detect a global privacy control setting, we will make reasonable efforts to respect your choice as required by applicable law.
You have the right to opt out of marketing communications we send you. If you no longer want to receive newsletter or other marketing content from us, you can reply to any email from us and ask to be removed, or contact us directly at patrick@bridgewell-advisory.com. Please be aware that you may continue to receive certain communications from us that are necessary in connection with an inquiry you have submitted.
Depending on your location, you may have the right to submit certain requests relating to your personal information based on applicable state laws. Please email us at patrick@bridgewell-advisory.com to submit data requests.
Under Nevada privacy law, please know we do not currently sell data triggering that statute’s opt-out requirements.
We may need to authenticate your identity before your request can be processed, which may require you to provide certain personal information that we will match against our records. You may designate an authorized agent to make a request on your behalf; however, you will still need to verify your identity directly with us before your request can be processed.
We will not discriminate against you in a manner prohibited by applicable state laws because you exercise your privacy rights. While you may request to delete your personal information, such deletion may affect our ability to respond to your inquiry.
Civil Code § 1798.83 permits California residents to request from us a notice disclosing: (1) the categories of personal information we have shared with third parties, if any, for the third parties’ direct marketing purposes, during the preceding calendar year, and (2) the names and addresses of those third parties. To make such a request, please contact us at patrick@bridgewell-advisory.com.
Our Site may contain links to other websites, such as LinkedIn. These websites may have privacy policies different from our Privacy Policy. Any interaction on third-party websites is governed not by this Privacy Policy but by the terms of use and privacy policy of that platform.
We use reasonable administrative, technical, and physical safeguards designed to protect your information, including HTTPS encryption and access controls. However, no method of transmission or storage is 100% secure.
We retain your data only for as long as necessary to fulfill the purposes outlined in this policy or as otherwise legally permitted or required, such as operating the Site, complying with our legal obligations, resolving disputes, and for safety, security, and fraud prevention. At the end of the retention period, personal data will be deleted, destroyed, or de-identified.
Our Site is not directed or targeted to children under the age of 16. We do not knowingly collect personal information from children. If you believe we have done so inadvertently, please contact us for removal.
Our Site and services are targeted to businesses in the United States. If you are visiting from outside the United States, be aware that your data may be transferred to and processed in the U.S. and other jurisdictions where our servers or service providers are located, which may have data protection laws different from those of your country or region. By using our Site, you agree and consent to such transfer of personal information to the United States.
We may update this Privacy Policy from time to time. The updated version will be indicated by an updated “Effective Date.” Continued use of the Site constitutes your acceptance of the revised policy.
If you have questions or concerns about this Privacy Policy, please contact:
Bridgewell Advisory
patrick@bridgewell-advisory.com
If you need to access this Privacy Policy in an alternative format due to a disability, please contact patrick@bridgewell-advisory.com.
The terms that govern your use of the Bridgewell Advisory website.
Effective Date: September 14, 2026
Welcome to Bridgewell Advisory (“Bridgewell,” “we,” “our,” or “us”), a service of Bridgewell LLC. By accessing or using our website at https://bridgewell-advisory.com, its subdomains, content, and services (the “Site”), you agree to be bound by the following Terms of Service (“Terms”). Please read these Terms carefully before using our Site.
These Terms govern your use of the Site only. They do not govern the scope, fees, or terms of any advisory engagement between Bridgewell and a client — those are set out exclusively in a separate, signed engagement letter between Bridgewell and that client.
THESE TERMS CONTAIN A BINDING ARBITRATION PROVISION AND CLASS ACTION WAIVER. YOU AGREE THAT DISPUTES BETWEEN US WILL BE RESOLVED BY BINDING, INDIVIDUAL ARBITRATION AND YOU AGREE TO WAIVE ANY RIGHT TO PARTICIPATE IN A CLASS ACTION OR REPRESENTATIVE ACTION. PLEASE READ THE SECTION TITLED “DISPUTE RESOLUTION” BELOW TO LEARN MORE.
By using our Site, you acknowledge that you have read, understood, and agree to comply with these Terms. If you do not agree with any part of these Terms, you must not use our Site.
You are granted a limited, non-exclusive, non-transferable license to access and use our Site for personal or internal business purposes in accordance with these Terms. You may not misuse our Site, engage in unauthorized activities, or violate any applicable laws or regulations.
As a user of the Site, you agree not to:
We reserve the right to terminate your use of the Site for violating any of these prohibited activities.
All content, trademarks, and materials available on our Site, including text, graphics, logos, and software, are the property of Bridgewell or its licensors and are protected by applicable copyright and trademark laws. You may not reproduce, distribute, or create derivative works from our content without prior written permission.
If you wish to make any use of the Site, content, or marks other than as set out in these Terms, please contact us at patrick@bridgewell-advisory.com. If we grant you permission to post, reproduce, or publicly display any part of our Site or content, you must identify us as the owner or licensor of that content and ensure any copyright or proprietary notice remains visible.
We reserve all rights not expressly granted to you in and to the Site, content, and marks. Any breach of this section will constitute a material breach of these Terms and your right to use our Site will terminate immediately.
If you directly send us any question, comment, suggestion, idea, or other feedback about the Site (“Feedback”), you agree to assign to us all intellectual property rights in that Feedback. You agree that we own the Feedback and are entitled to its unrestricted use and dissemination for any lawful purpose, without acknowledgment or compensation to you.
THE SITE IS PROVIDED ON AN AS-IS AND AS-AVAILABLE BASIS. YOUR USE OF THE SITE IS AT YOUR SOLE RISK. TO THE FULLEST EXTENT PERMITTED BY LAW, WE DISCLAIM ALL WARRANTIES, EXPRESS OR IMPLIED, IN CONNECTION WITH THE SITE, INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.
WE MAKE NO WARRANTIES OR REPRESENTATIONS ABOUT THE ACCURACY OR COMPLETENESS OF THE SITE’S CONTENT OR THE CONTENT OF ANY THIRD-PARTY SITES LINKED TO THE SITE, AND WE ASSUME NO LIABILITY FOR ERRORS OR INACCURACIES IN THAT CONTENT, ANY UNAUTHORIZED ACCESS TO OUR SERVERS, ANY INTERRUPTION OR CESSATION OF TRANSMISSION TO OR FROM THE SITE, OR ANY VIRUSES OR OTHER HARMFUL COMPONENTS TRANSMITTED TO OR THROUGH THE SITE BY ANY THIRD PARTY.
TO THE FULLEST EXTENT PERMITTED BY LAW, IN NO EVENT WILL BRIDGEWELL OR ITS DIRECTORS, EMPLOYEES, OR AGENTS BE LIABLE TO YOU OR ANY THIRD PARTY FOR ANY INDIRECT, CONSEQUENTIAL, EXEMPLARY, INCIDENTAL, SPECIAL, OR PUNITIVE DAMAGES ARISING FROM YOUR USE OF THE SITE, EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. OUR LIABILITY TO YOU FOR ANY CAUSE ARISING FROM YOUR USE OF THE SITE WILL AT ALL TIMES BE LIMITED TO THE LESSER OF THE AMOUNT PAID, IF ANY, BY YOU TO US DURING THE TWELVE (12) MONTHS PRIOR TO THE CAUSE OF ACTION ARISING, OR $100.00 USD. THIS LIMITATION APPLIES ONLY TO YOUR USE OF THE SITE AND DOES NOT LIMIT BRIDGEWELL’S LIABILITY UNDER ANY SEPARATE SIGNED ENGAGEMENT LETTER. CERTAIN STATE AND INTERNATIONAL LAWS DO NOT ALLOW LIMITATIONS ON IMPLIED WARRANTIES OR THE EXCLUSION OR LIMITATION OF CERTAIN DAMAGES; IF THOSE LAWS APPLY TO YOU, SOME OR ALL OF THE ABOVE LIMITATIONS MAY NOT APPLY, AND YOU MAY HAVE ADDITIONAL RIGHTS.
We care about data privacy and security. Please review our Privacy Policy. By using the Site, you agree to be bound by our Privacy Policy, which is incorporated into these Terms. The Site is hosted in the United States; if you access the Site from another region with data protection laws that differ from those of the United States, your continued use of the Site means you are transferring your data to, and consenting to have it processed in, the United States.
You agree to defend, indemnify, and hold Bridgewell harmless, including its officers, agents, partners, and employees, from and against any loss, damage, liability, claim, or demand, including reasonable attorneys’ fees, arising out of your use of the Site, your breach of these Terms, or your violation of applicable law. We reserve the right, at your expense, to assume the exclusive defense of any matter for which you are required to indemnify us, and you agree to cooperate with that defense. We will use reasonable efforts to notify you of any claim subject to this indemnification.
These Terms remain in full force and effect while you use the Site. We reserve the right to suspend or terminate your access to the Site at any time, for any reason, including a violation of these Terms.
These Terms are governed by and construed in accordance with the laws of the State of Tennessee, without regard to its conflict-of-law provisions.
The Site may contain links to websites operated by other parties. Such links are not investigated, monitored, or checked for accuracy by us, and we are not responsible for the content, accuracy, or policies of any third-party site. A link does not imply our endorsement. If you leave the Site to access a third-party link, you do so at your own risk, and these Terms no longer govern your use of that site.
To expedite resolution and control the cost of any dispute, controversy, or claim related to these Terms or the Site (a “Dispute”), the parties agree to first attempt to negotiate any Dispute informally for at least thirty (30) days before initiating arbitration. Informal negotiations commence upon written notice from one party to the other.
If the parties are unable to resolve a Dispute through informal negotiations, the Dispute will be finally and exclusively resolved by binding arbitration, except as provided under “Exceptions” below. YOU UNDERSTAND THAT WITHOUT THIS PROVISION, YOU WOULD HAVE THE RIGHT TO SUE IN COURT AND HAVE A JURY TRIAL. The arbitration will be commenced and conducted under the Commercial Arbitration Rules of the American Arbitration Association (“AAA”), available at the AAA’s website. The arbitration may be conducted in person, through the submission of documents, or remotely by phone or online. The arbitrator will make a decision in writing and must follow applicable law.
If you intend to seek arbitration, you must first send a written notice (“Notice”), by first class or certified mail, to: Bridgewell LLC, [mailing address to be added]. The Notice must describe the nature and basis of the claim and the specific relief sought. If the parties cannot reach agreement within 30 days of the Notice, either party may initiate arbitration proceedings through the AAA at www.adr.org, and the initiating party must also mail a copy of the completed form to the other party. You may send your copy to patrick@bridgewell-advisory.com.
If a Dispute proceeds in court rather than arbitration, it will be commenced in the state or federal courts located in Davidson County, Tennessee, and the parties consent to personal jurisdiction and venue in those courts. No Dispute may be commenced more than one (1) year after the cause of action arose. Each party will bear its own attorneys’ fees and costs incurred in connection with any Dispute.
Any arbitration is limited to the Dispute between the parties individually. To the full extent permitted by law: no arbitration will be joined with any other proceeding; there is no right to arbitrate any Dispute on a class-action basis; and there is no right to bring any Dispute in a representative capacity on behalf of the general public or any other persons.
The parties agree the following Disputes are not subject to the informal negotiation and arbitration provisions above: (a) Disputes seeking to enforce or protect, or concerning the validity of, either party’s intellectual property rights; (b) Disputes related to allegations of theft, piracy, invasion of privacy, or unauthorized use; and (c) any claim for injunctive relief.
Visiting or using the Site, and sending us emails, constitute electronic communications. You consent to receive electronic communications, and you agree that all agreements, notices, disclosures, and other communications we provide electronically satisfy any legal requirement that such communications be in writing.
We reserve the right to update or modify these Terms at any time. Any changes are effective immediately upon posting on this page. Continued use of the Site following a change indicates your acceptance of the revised Terms.
If you have questions about these Terms, please contact us at patrick@bridgewell-advisory.com.